Valeo Financial Advisors, LLC Clovis Oncology, Inc. Transaction History

Valeo Financial Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$4.06 - $5.8 $50,749 - $72,500	-12,500 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$5.02 - $7.05 $50,199 - $70,500	10,000 Added 400.0%	12,500 $72,000
Q1 2020 Apr 13, 2020	BUY	$3.77 - $11.0 $9,425 - $27,500	2,500 New	2,500 $17,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.